Last reviewed · How we verify
[¹⁴C]Etelcalcetide
At a glance
| Generic name | [¹⁴C]Etelcalcetide |
|---|---|
| Also known as | AMG 416, Parsabiv™ |
| Sponsor | Amgen |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [¹⁴C]Etelcalcetide CI brief — competitive landscape report
- [¹⁴C]Etelcalcetide updates RSS · CI watch RSS
- Amgen portfolio CI